BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23770716)

  • 1. Irinotecan combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Zhang S; Chen Z; Yang R; Chen J; Cheng P; He Z; Liu Z; Qi Z
    Cell Immunol; 2013 Apr; 282(2):85-92. PubMed ID: 23770716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
    Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isatis tinctoria L. combined with co-stimulatory molecules blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Kang X; Chen J; Qin Q; Wang F; Wang Y; Lan T; Xu S; Wang F; Xia J; Ekberg H; Qi Z; Liu Z
    Transpl Immunol; 2010 May; 23(1-2):34-9. PubMed ID: 20338239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined costimulation blockade inhibits accelerated rejection mediated by alloantigen-primed memory T cells in mice.
    Xie B; Chen J; Xia J; Wang Y; Liang H; Ekberg H; Corbascio M; Qi Z
    Immunol Invest; 2009; 38(7):639-51. PubMed ID: 19811427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44/CD70 blockade and anti-CD154/LFA-1 treatment synergistically suppress accelerated rejection and prolong cardiac allograft survival in mice.
    Shao W; Yan G; Lin Y; Chen J; Dai H; Wang F; Xi Y; Thorlacius H; Qi Z
    Scand J Immunol; 2011 Nov; 74(5):430-7. PubMed ID: 21707692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of monoclonal antibodies with DST inhibits accelerated rejection mediated by memory T cells to induce long-lived heart allograft acceptance in mice.
    Shao W; Chen J; Dai H; Peng Y; Wang F; Xia J; Thorlacius H; Zhu Q; Qi Z
    Immunol Lett; 2011 Aug; 138(2):122-8. PubMed ID: 21477620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred mice.
    Lin Y; Dai H; Su J; Yan G; Xi Y; Ekberg H; Chen J; Qi Z
    Transpl Immunol; 2011 Dec; 25(4):194-201. PubMed ID: 21856422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
    Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
    Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4(+) memory T cells in nude mice.
    Wang F; Chen J; Shao W; Xie B; Wang Y; Lan T; Thorlacius H; Qi Z
    Immunol Invest; 2010; 39(8):807-19. PubMed ID: 20718664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of alloantigen-primed memory CD4+ and CD8+ T cells by hematopoietic chimerism in mice.
    Lan T; Chen J; Xia J; Wang Y; Xie B; Wang F; Qi Z
    Scand J Immunol; 2010 Aug; 72(2):86-93. PubMed ID: 20618766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
    Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
    Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients.
    Shariff H; Tanriver Y; Brown KL; Meader L; Greenlaw R; Mamode N; Jurcevic S
    Transplantation; 2010 Aug; 90(3):270-8. PubMed ID: 20571468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft.
    Kwun J; Farris AB; Song H; Mahle WT; Burlingham WJ; Knechtle SJ
    Transplantation; 2015 Dec; 99(12):2485-93. PubMed ID: 26102611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
    Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.